Health Catalyst in agreement to buy Twistle for $104.5 million
Leaders expect this will spawn a go-to-market solution that addresses population health needs on a global scale.
June 25, 2021 / Jeff Lagasse, Associate Editor
Data and analytics technology and services provider Health Catalyst has entered into an agreement to acquire Twistle, the company said this week. Based in Albuquerque, New Mexico, Twistle is a healthcare patient engagement SaaS technology company that automates patient-centered, HIPAA-compliant communication between care teams and patients.
A filing Thursday with the Securities and Exchange Commission places the value of the deal at $104.5 million, plus a potential “earn-out” of up to $65 million. The earn-out, as described in the filing, means Health Catalyst could issue additional shares of its common stock if certain performance targets are met before June 30, 2022.
The number of shares that are issued will be determined by how close performance comes to those benchmarks.
WHAT’S THE IMPACT
Twistle’s main goals are to drive better outcomes and reduce healthcare costs. Branding itself as essentially a “GPS” for the healthcare system, Twistle offers “turn by turn” guidance to patients as they navigate the system before, during and after a care episode. It does so through automation combined with multi-channel communication, such as secure text messaging, patient portals and interactive voice responses.